Good morning :)
Switch to
Add to Watchlist

Genomic Valley Biotech Ltd

GVBL
Health CareMiscellaneous
SmallcapWith a market cap of ₹7 cr, stock is ranked 3,392
Low RiskStock is 1.18x as volatile as Nifty
23.600.00 (+0.00%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CareMiscellaneous
SmallcapWith a market cap of ₹7 cr, stock is ranked 3,392
Low RiskStock is 1.18x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
-12.65
PB RatioPB Ratio
1.43
Dividend YieldDiv. Yield
Sector PESector PE
40.38
Sector PBSector PB
5.77
Sector Div YldSctr Div Yld
0.61%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Genomic Valley Biotech Ltd is conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20182019202020210.621.000.860.210.030.240.29-0.57
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Company Update 
Announced OnJul 9, 2021
Genomic Valley Biotech Ltd - 539206 - Statement Of Investor Complaints For The Quarter Ended June 2021
Genomic Valley Biotech Ltd - 539206 - Statement Of Investor Complaints For The Quarter Ended June 2021
Company Update 
Announced OnJul 9, 2021

Genomic Valley Biotech Ltd - 539206 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | Download

Genomic Valley Biotech Ltd - 539206 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | Download

Company Update 
Announced OnJul 7, 2021
Genomic Valley Biotech Ltd - 539206 - Shareholding for the Period Ended June 30, 2021
Genomic Valley Biotech Ltd - 539206 - Shareholding for the Period Ended June 30, 2021
See all events